VRAX Virax Biolabs Group Ltd

VRAX financial statements, revenue, balance sheet, cash flow, and SEC filings

CIK: 1885827 Exchange: Nasdaq SIC: 2835 (In Vitro & In Vivo Diagnostic Substances) Data checked: Oct 21, 2026

Filer Category

Non-accelerated filer<br>Emerging growth company

Entity Type

Other

Industry (SIC)

2835 In Vitro & In Vivo Diagnostic Substances

Incorporated

Fiscal Year End

March (0331)

Phone

44 020 7788 7414

EIN

000000000

Headquarters

LANARKSHIRE, X0, ML1 5UH

Former Names: Virax Biolabs (Cayman) Ltd (2021–2021)

📊

No supported financial periods are available for this company.